Spruce BiosciencesSPRB
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 38 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, down 12 from Q1 2024. 5 opened new positions and 17 sold out. The largest holders were RiverVest Venture Management LLC ($1.5M), Carlyle Group Inc. ($1.5M) and Rock Springs Capital Management LP ($1.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E109
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $293K |
| Exits | 17 | $1.8M |
All 13F filers, Q1 2024 → Q2 2024: 1,963,433 shares bought and 3,343,654 shares sold, net −1,380,221 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| RiverVest Venture Management LLC | 22.27% | No change | 2,936,281 | $1.5M |
| Carlyle Group Inc. | 0.14% | No change | 2,896,518 | $1.5M |
| Rock Springs Capital Management LP | 0.04% | No change | 2,609,125 | $1.4M |
| Rosalind Advisors, Inc. | 0.62% | No change | 1,508,419 | $781K |
| Acadian Asset Management LLC | 0.00% | Add +270.9% | 1,367,997 | $707K |
| Vanguard Group Inc. | 0.00% | No change | 863,375 | $447K |
| Altium Capital Management LLC | 0.17% | Reduce -29.5% | 811,167 | $420K |
| Sands Capital Alternatives, LLC | 0.14% | No change | 787,007 | $409K |
| Almitas Capital LLC | 0.09% | New | 396,506 | $205K |
| ExodusPoint Capital Management, LP | 0.00% | Add +72.0% | 386,702 | $200K |
| Renaissance Technologies | 0.00% | Add +35.1% | 366,100 | $190K |
| ADAR1 Capital Management, LLC | 0.04% | Reduce -2.7% | 355,216 | $184K |
| Geode Capital Management, LLC | 0.00% | Add +1.9% | 204,002 | $106K |
| 683 Capital Management, LLC | 0.01% | New | 140,934 | $73K |
| UBS Group AG | 0.00% | Add +734.2% | 131,923 | $68K |
| BlackRock Inc. | 0.00% | Reduce -32.9% | 124,734 | $65K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 85,000 | $44K |
| Citadel Advisors | 0.00% | Reduce -3.6% | 84,715 | $44K |
| Superstring Capital Management LP | 0.05% | Reduce -82.3% | 77,992 | $40K |
| Lion Point Capital, LP | 0.12% | No change | 75,000 | $39K |
| Northern Trust Corp. | 0.00% | Reduce -0.0% | 74,927 | $39K |
| State Street Corp. | 0.00% | No change | 64,400 | $33K |
| Two Sigma Advisers, LP | 0.00% | Reduce -49.4% | 45,700 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +189.6% | 33,087 | $17K |
| Jane Street Group, LLC | 0.00% | Reduce -60.7% | 30,848 | $16K |
| Two Sigma Investments, LP | 0.00% | Reduce -76.8% | 28,584 | $15K |
| XTX Topco Ltd | 0.00% | Reduce -52.1% | 27,185 | $14K |
| Privium Fund Management (UK) Ltd | 0.01% | No change | 24,554 | $13K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 15,289 | $8K |
| Marex Group Ltd | 0.00% | New | 14,800 | $8K |
| Shay Capital LLC | 0.00% | New | 13,172 | $7K |
| Group One Trading LLC | 0.00% | Reduce -2.5% | 3,839 | $2K |
| Morgan Stanley | 0.00% | Reduce -90.1% | 2,133 | $1K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1,000 | $518 |
| Bank of America Corp. | 0.00% | Reduce -99.4% | 150 | $78 |
| JPMorgan Chase & Co. | 0.00% | Add +554.5% | 72 | $38 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -100.0% | 2 | $1 |
| Royal Bank of Canada | 0.00% | New | 216 | $0 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.